Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer | Citedby Results | Onkologie | Karger Publishers

Skip to Main Content

Skip Nav Destination

Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

Onkologie (2010) 33 (8-9): 466–469.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Predictive factors for EGFR -tyrosine kinase inhibitor retreatment in patients with EGFR -mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study

Gee-Chen Chang
Chien-Hua Tseng
Kuo-Hsuan Hsu
Chong-Jen Yu
Cheng-Ta Yang
Kun-Chieh Chen
Tsung-Ying Yang
Jeng-Sen Tseng
Chien-Ying Liu
Wei-Yu Liao
Te-Chun Hsia
Chih-Yen Tu
Meng-Chih Lin
Ying-Huang Tsai
Meng-Jer Hsieh
Wen-Shuo Wu
Yuh-Min Chen

Lung Cancer (2017) 104: 58.

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure

Kyoung Min Cho
Bhumsuk Keam
Tae Min Kim
Se-Hoon Lee
Dong-Wan Kim
Dae Seog Heo

The Korean Journal of Internal Medicine (2015) 30 (6): 891.

Subsequent Treatment Choices for Patients with Acquired Resistance to EGFR-TKIs in Non-small Cell Lung Cancer: Restore after a Drug Holiday or Switch to another EGFR-TKI?

Tao Song
Wei Yu
Shi-Xiu Wu

Asian Pacific Journal of Cancer Prevention (2014) 15 (1): 205.

Research progress in the use of combinations of platinum-based chemotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors

Chi Pan
Suzhan Zhang
Jianjin Huang

The Chinese-German Journal of Clinical Oncology (2013) 12 (3): 133.

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Hye Jin Kim
Hwang-Phill Kim
Young-Kwang Yoon
Maeng-Sup Kim
Gwan-Sun Lee
Sae-Won Han
Seock-Ah Im
Tae-You Kim
Do-Youn Oh
Yung-Jue Bang

Anti-Cancer Drugs (2012) 23 (3): 288.

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines

Hyun-Jin Nam
Hwang-Phill Kim
Young-Kwang Yoon
Sang-Hyun Song
Ah-Rum Min
Sae-Won Han
Seock-Ah Im
Tae-You Kim
Do-Youn Oh
Yung-Jue Bang

Investigational New Drugs (2012) 30 (6): 2148.

First BRET‐based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors

Caroline Corbel
Qian Wang
Hadjira Bousserouel
Amel Hamdi
Bing Zhang
Olivier Lozach
Yoan Ferandin
Vincent B. C. Tan
Françoise Guéritte
Pierre Colas
Cyril Couturier
Stéphane Bach

Biotechnology Journal (2011) 6 (7): 860.

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer

Hyun-Jin Nam
Hwang-Phill Kim
Young-Kwang Yoon
Hyung-Seok Hur
Sang-Hyun Song
Maeng-Sup Kim
Gwan-Sun Lee
Sae-Won Han
Seock-Ah Im
Tae-You Kim
Do-Youn Oh
Yung-Jue Bang

Cancer Letters (2011) 302 (2): 155.

Glutathione‐S‐transferase P1 is a critical regulator of Cdk5 kinase activity

Kai‐Hui Sun
Kuei‐Hua Chang
Sara Clawson
Soumitra Ghosh
Hamid Mirzaei
Fred Regnier
Kavita Shah

Journal of Neurochemistry (2011) 118 (5): 902.

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Renhua Guo
Xiaofen Chen
Tongshan Wang
Zhiyuan Zhang
Jin Sun
Yongqian Shu

BMC Cancer (2011) 11 (1)